Received: from DS2PR20MB7804.namprd20.prod.outlook.com (2603:10b6:8:2d2::10) by DM6PR20MB2313.namprd20.prod.outlook.com with HTTPS; Fri, 14 Aug 2026 01:45:27 +0000 Received: from PH8P223CA0029.NAMP223.PROD.OUTLOOK.COM (2603:10b6:510:2db::25) by DS2PR20MB7804.namprd20.prod.outlook.com (2603:10b6:8:2d2::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.315.13; Fri, 14 Aug 2026 01:45:24 +0000 Received: from CY4PEPF0000FCC2.namprd03.prod.outlook.com (2603:10b6:510:2db:cafe::32) by PH8P223CA0029.outlook.office365.com (2603:10b6:510:2db::25) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.315.15 via Frontend Transport; Fri, 14 Aug 2026 01:45:24 +0000 Authentication-Results: spf=pass (sender IP is 157.205.202.130) smtp.mailfrom=takashima-pat.jp; dkim=pass (signature was verified) header.d=alpha-prm.jp;dmarc=pass action=none header.from=takashima-pat.jp;compauth=pass reason=100 Received-SPF: Pass (protection.outlook.com: domain of takashima-pat.jp designates 157.205.202.130 as permitted sender) receiver=protection.outlook.com; client-ip=157.205.202.130; helo=sgmmta42-fen.alpha-prm.jp; pr=C Received: from sgmmta42-fen.alpha-prm.jp (157.205.202.130) by CY4PEPF0000FCC2.mail.protection.outlook.com (10.167.242.104) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.339.3 via Frontend Transport; Fri, 14 Aug 2026 01:45:23 +0000 Received: from sgmmta66-fen.alpha-prm.jp ([157.205.202.204]) by sgmmta42.alpha-prm.jp with ESMTP id <20260814014522.MAZO15541.sgmmta42.alpha-prm.jp@sgmmta66-fen.alpha-prm.jp> for ; Fri, 14 Aug 2026 10:45:22 +0900 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=alpha-prm.jp; s=alm01; t=1786671922; bh=y+SzPZPVYxuOAp7oDdotbvbKuo+YwLwkgQ9W7y8i1CM=; h=From:To:Subject:Date:Message-ID:MIME-Version; b=mW4OcV3ODPGweD5q9NJ+WJhk1MIPysQthaNcrS7ruqlEd9fI3HR5Moug7rt7VJCquBM7fkY+pn+xNbbCh/O2lC4ZApBHzT6l7Qp7Q4tGX2OtJlBSyp2JOTdjParebGJo9CiyMNL2ldxx+VQVjQ10t2Sw0BCKGxFl052o9mA1W6HWnKUABoycBNvn5vikDh0LaHnaf5fvr/iRnh075JVhrEp5tFQBORhqvv37DCeO81LeUTCH9WbSwT/LjITnvPX6xc+E9iWnxk0yU5QS+pQsSrTzA2kMxjKxitCGW2iz+cSrFU/pT5ZTWzjdY2SjKbM6pgNTtx1ZgzWvCz3hUWjxZA== Received: from sgmtsf13_tsfppi.alpha-prm.jp ([157.205.230.86]) by sgmmta66.alpha-prm.jp with ESMTP id <20260814014522.ICXT15909.sgmmta66.alpha-prm.jp@sgmtsf13_tsfppi.alpha-prm.jp>; Fri, 14 Aug 2026 10:45:22 +0900 Received: from sgmtsf13_tsfppo.alpha-prm.jp (localhost [127.0.0.1]) by sgmtsf13_tsfppi.alpha-prm.jp (Postfix) with ESMTP id 09CA24000074; Fri, 14 Aug 2026 10:45:22 +0900 (JST) Received: from sgmtsf13_tsfccm.alpha-prm.jp (localhost [127.0.0.1]) by sgmtsf13_tsfppo.alpha-prm.jp (Postfix) with ESMTP id 093094000075; Fri, 14 Aug 2026 10:45:22 +0900 (JST) Received: from sgmmsa53.alpha-prm.jp (sgmmsa53-fen.alpha-prm.jp [157.205.201.12]) by sgmtsf13_tsfccm.alpha-prm.jp (Postfix) with ESMTP id 068F24000074; Fri, 14 Aug 2026 10:45:22 +0900 (JST) Received: from Toma3 ([133.32.51.249]) by sgmmsa53.alpha-prm.jp with ESMTP id <20260814014522.QXIF15218.sgmmsa53.alpha-prm.jp@Toma3>; Fri, 14 Aug 2026 10:45:22 +0900 X-RazorGate-Vade: 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 From: To: CC: Subject: Venezuelan Patent Application No. 2015-000333 (Your Ref.:18710, Our Ref.:462924) Date: Fri, 14 Aug 2026 10:45:21 +0900 Message-ID: <005c01dd2b8e$919da100$b4d8e300$@takashima-pat.jp> Content-Type: multipart/alternative; boundary="----=_NextPart_000_005D_01DD2BDA.01854900" X-Mailer: Microsoft Outlook 16.0 Thread-Index: Ad0riQ/7VAIOOctJRqK0qItT+DCf9w== Content-Language: ja Return-Path: mail@takashima-pat.jp X-MS-Exchange-Organization-ExpirationStartTime: 14 Aug 2026 01:45:24.0169 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 6ac158a4-cdd1-48b5-2680-08def9a5b552 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 5b2d099d-6629-44d8-9498-c19d292dc0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: CY4PEPF0000FCC2:EE_|DS2PR20MB7804:EE_|DM6PR20MB2313:EE_ X-MS-Exchange-Organization-AuthSource: CY4PEPF0000FCC2.namprd03.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 6ac158a4-cdd1-48b5-2680-08def9a5b552 X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704162311799003|2092899012|41022699024|12012899012|3072899012|57112099003|16102099003|5063699009|18003699003|8096899003|13003099007|19002099009|10067099003; X-Forefront-Antispam-Report: CIP:157.205.202.130;CTRY:JP;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:sgmmta42-fen.alpha-prm.jp;PTR:sgmmta42-fen.alpha-prm.jp;CAT:NONE;SFS:(13230040)(704162311799003)(2092899012)(41022699024)(12012899012)(3072899012)(57112099003)(16102099003)(5063699009)(18003699003)(8096899003)(13003099007)(19002099009)(10067099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 14 Aug 2026 01:45:23.4731 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 6ac158a4-cdd1-48b5-2680-08def9a5b552 X-MS-Exchange-CrossTenant-Id: 5b2d099d-6629-44d8-9498-c19d292dc0e2 X-MS-Exchange-CrossTenant-AuthSource: CY4PEPF0000FCC2.namprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: DS2PR20MB7804 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.3208926 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0315.000 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?tMA3NmVVjz7bp3xd4BETY0uDHKERL18KuEE22rz3dBgPuxRrhsYgc/hM65Wz?= =?us-ascii?Q?W/vPELkk7jWmXZfxIevR3w9r3HK/Qdv8PpEWLEgluCklWnK1c7e5dLTMbf4e?= =?us-ascii?Q?qI1iY5yFOh1dRQ+lc2uZ7HSuk813MCu9Zjh8O/Yo9Ll7vkb4+6uHtEEzeLLJ?= =?us-ascii?Q?i3LdNrzH30dRUxoDVnTu4v1Slkpbytx6N0hw7UQMSr6sGB2LxZOfgl98yTeV?= =?us-ascii?Q?O2mmBJjOhTUlC08nvvbi18ZFoK/ck77JTqnyEapIq02WeOcw6jf6vXZwJh2X?= =?us-ascii?Q?Lju6Z3L6DEDJsIsNQYWtk8qIfkB/LzyVJNt80dEJFnu2C5rLOlK7lsgIdEEn?= =?us-ascii?Q?I1I5w1zmnbN975vUjJn0PjdNGZgwplliIWLBzHizipBEq0CEA+zSB5jkAhqC?= =?us-ascii?Q?iFSvsTmhzg2ggmoQEqxh0TptoRtsHAnzPYxrfzLIRZVJB2mxRsZB/yw/qxPt?= =?us-ascii?Q?zl13lR2p5yHLafbztdS8dItt4pxi8C0kHl95L3R+ZlHj0MQulfXvXKZs4ipj?= =?us-ascii?Q?FlR0e8Ph3ccUzWcyvvoVXlS3tv//KHTnArt4McZcHgmb0OW8gW/9XmfU8Hcm?= =?us-ascii?Q?kYesJFuGdMAYJAFBztMfNFQcac5kcrapsvSzOWf09gidjv2sgrOVBHTp9XCB?= =?us-ascii?Q?sQ616e2xyXbCwjDQRYfahTYK3YtFZ0CbyDOswEFknxwf61f9CYqX4ParBDtv?= =?us-ascii?Q?r1sdv5q757dcLnImQMAdLSbd1Mo8aWDfhQ2YUWrYO0lj8pGSG8BlEE6hhZFe?= =?us-ascii?Q?gwWZyZ14+EZIIpuZTLQLHdqz4ezeCDNOHFW7zmIzNvGDCle3IBAY7RmZPIkk?= =?us-ascii?Q?/9HQSRQyJeJalMunBSF5JgdbaDpdMR0tMEl0nm4x9L4Oo0i/co5SKFcSvIBO?= =?us-ascii?Q?mHAgxbXdPk8pNl0HQxs9SdbCJlZfG/ZkbA4vJuwZTrtsPyZctRGP9s89ARKY?= =?us-ascii?Q?lw/pbXZ1x/eLxdI95H2Mx5eZb97py7SsbabgZgcuC39RBAxuqGehG+3cw8C+?= =?us-ascii?Q?fhboEDVnzmoF7twXhxH6SJ7KTtWRjahrjyRM/f5We0ssBEtJQaUi/uPtvyPI?= =?us-ascii?Q?gK9eNpLC7p8mDOKenYWvxXLw98XGIwat7WcsAEUQjoQaAcpdFoqTaZfZmuyd?= =?us-ascii?Q?48Z9tvFkGZoDGATZfpuZw6dkcuTlbLtHHdKBZQTJ4bn7L1eAwAMIDJ6xpzAH?= =?us-ascii?Q?Wpt23v40nr17XEquv8D7u5xJ6GUACTWfvSwKNHp0neuaNekFLTrdEEQeBXEV?= =?us-ascii?Q?L2Fr351N0UwPeKxIiiXJo/i4+CvtwU+ga9eu8gBzZsHCyScYOoBBEZq1SCdc?= =?us-ascii?Q?YQ+H+TCFN449H3ubyMRtc7I01KHeqysIIuBEVxCRYtka8RMnsAeHkYQQdaP2?= =?us-ascii?Q?eJUs3WBr21WV8LGXPTXIu2D7CEcBXqQZqbH9I+1HS8tOz+XtyhG6XYHZle59?= =?us-ascii?Q?1cDvTPTswPaNbzOdm3u2Wxefwq1NO0Uek5wNdmIno7DdVAeczJ5KPbGd5l7X?= =?us-ascii?Q?RzzUcWiRH219lKhQoZGo/RoKy1iJ56mS3lfrnkPb4l0vljCS46+f9M6wcFvW?= =?us-ascii?Q?9vpvYtVanSCUmyzPhlyTA463X+KYtbYSe6GskT+IIWf+WBt/B8hwf/NGkZ7k?= =?us-ascii?Q?4BIwsh+eYwliRni6uZsi1p6yood8E2/G0WUJFbjpuNniP/JhIt2FNybWeWJS?= =?us-ascii?Q?GXJOM68Uslq8lKBeQZ2+p9aPUlFel4jcePcKnNuufhfxWMy4rMruYteb2UTT?= =?us-ascii?Q?0HPriCX5VrJFSjSkYQCKrRjESydkjk9kNwKgBUbi1yvcLYGT/XNNqeaACkLX?= =?us-ascii?Q?4EGp0yVtpXALXF3vHPJ3sLNtkVXuoopzbn/UBuKJ0qX5s6OmolXkCFE2q3bg?= =?us-ascii?Q?vfcwpMZd5Fqe/BDdlmLFgcBMBd5VzpkGXr5IIYwxbme/KDb/w1trkrhTD16K?= =?us-ascii?Q?rsiOroXYnZHWSdtJ/ulgvjJSu7UcphMaqT27vQZkuopXcUzo7pSwgfvmb0WY?= =?us-ascii?Q?LJ6Ng5UwmFuD5ZQs9aJXyGRR/lR+L39m5lzSq0qy8xyr8ZFIg8ylcR4LQTTb?= =?us-ascii?Q?HHLKCW3qsLlFRFLIe9kyGKwe6HLIPn7puRZgEcmWd71eTuvtrYuEhLe8SZqB?= =?us-ascii?Q?GOsRTU7En7i8dfsCTccQYeW/TFR5M5tW2lf0pLpqoGgcLx5rVyrSoWANn/EN?= =?us-ascii?Q?itnc+MUwi7rXgWgrQsNX0GnG6zupJyV0WAgs30SpsnIuA78UQnm+GDshs2gp?= =?us-ascii?Q?tYlwR/+fxlQbrJTvX1ecSQAVYPCfC0ydE9n68WIcbQwVW9Os7pbv4G7uGxRS?= =?us-ascii?Q?Asyqby1x9jtJRPsIneBDW10u?= MIME-Version: 1.0 ------=_NextPart_000_005D_01DD2BDA.01854900 Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: 7bit Venezuelan Patent Application No. 2015-000333 Applicant : Takeda Pharmaceutical Company Limited Your Ref. : 18710 Our Ref. : 462924 Dear Sirs: The Applicant has now decided to again allow the above-identified application to lapse at this stage. Therefore, please take, if necessary, the appropriate steps to abandon this application in a most economical way, and close your file accordingly. We look forward to a next opportunity to work with you again. Please acknowledge receipt of this email by return. Very truly yours, Mitsunori Kamada/mt/yk ****************************************************** TAKASHIMA International Patent Office (OSAKA OFFICE) Meiji Yasuda Seimei Osaka Midosuji Building (LAND AXIS TOWER) 1-1, Fushimimachi 4-chome, Chuo-ku, Osaka 541-0044 Japan TEL: 81-6-6227-1156 FAX: 81-6-6227-0260 MAIL: mail@takashima-pat.jp URL: https://www.takashima-pat.jp/english/ ****************************************************** ------=_NextPart_000_005D_01DD2BDA.01854900 Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable

Venezuelan Patent Application No. 2015-000333 =

Applicant : Takeda Pharmaceutical Company Li= mited

Your Ref. : 18710

Our= Ref. : 462924

 

Dear Sirs:

 

The Applicant has now decided to again allow the a= bove-identified application to lapse at this stage.  Therefore, please= take, if necessary, the appropriate ste= ps to abandon this application in a most economical way, and close your fil= e accordingly. 

 

We look forward to a next opportunity to work with you again.=  

<= o:p> 

Ple= ase acknowledge receipt of this email by= return.

=  

Very = truly yours,

 

Mitsunori Kamada/mt/yk

*****************************************************= *

TAKASHIMA International Patent Office (OSAKA OFFICE)

Meiji Yasuda Seimei Osaka Midosuji Building

1-1, Fushimimachi 4-chome, Chuo-ku,

Osaka 541-0044 Japan

TEL: 81-6-6227-1156<= /p>

FAX: 81= -6-6227-0260

MAIL: mail= @takashima-pat.jp 

URL:  https://www.takashima-pat.jp/english/

******************************************************

 

= ------=_NextPart_000_005D_01DD2BDA.01854900--